Caplin Point Laboratories per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹87.53₹84.36₹70.57₹60.19₹49.62
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹87.28₹84.11₹70.25₹59.90₹49.18
₹471.90₹471.90₹375.06₹304.90₹247.76
₹300.96₹287.79₹254.93₹223.05₹193.25
—₹68.85₹56.89₹40.95₹35.79
₹36.20₹36.20₹31.69₹21.75₹10.26
—₹6.00₹5.00₹4.50₹3.99
7.67.67.67.67.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CAPLIPOINT₹2,376.10

Caplin Point Laboratories Ltd.

· Pharma & Health
₹ CrorePeersAJANTPHARMERISGLANDBLUEJETCONCORDBIOACUTAASEMCUREGRANULESMcap ₹18,058 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS49.6260.1970.5784.3687.53
Diluted EPS49.1859.9070.2584.1187.28
Book Value per Share247.76304.90375.06471.90471.90
Revenue per Share193.25223.05254.93287.79300.96
Cash Flow per Share35.7940.9556.8968.85—
Free Cash Flow per Share10.2621.7531.6936.2036.20
Dividends per Share3.994.505.006.00—
Shares Outstanding (cr)7.67.67.67.67.6
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.